Advancements in the oral delivery of Docetaxel: challenges, current state-of-the-art and future trends

Autor: Sohail MF, Rehman M, Sarwar HS, Naveed S, Salman O, Bukhari NI, Hussain I, Webster TJ, Shahnaz G

Publikováno v: International Journal of Nanomedicine, Vol Volume 13, Pp 3145-3161 (2018)

Muhammad Farhan Sohail,1–3 Mubashar Rehman,4,5 Hafiz Shoaib Sarwar,2 Sara Naveed,1 Omer Salman,6 Nadeem Irfan Bukhari,7 Irshad Hussain,3 Thomas J Webster,5 Gul Shahnaz21Riphah Institute of Pharmaceutical Sciences, Riphah International University, L

Externí odkaz: https://doaj.org/article/315cf62a23d74bb081c1d474a42970e4

Exploring the potential of nanomedicine for gene therapy across the physicochemical and cellular barriers.

Autor: Hameed H; Faculty of Pharmaceutical Sciences, University of Central Punjab (UCP), Lahore, 54000, Pakistan. huma.hameed@ucp.edu.pk., Sarwar HS; Faculty of Pharmaceutical Sciences, University of Central Punjab (UCP), Lahore, 54000, Pakistan., Younas K; Faculty of Pharmacy, University Paris Saclay, 17 Avenue des sciences, 91190, Orsay, France., Zaman M; Faculty of Pharmaceutical Sciences, University of Central Punjab (UCP), Lahore, 54000, Pakistan., Jamshaid M; Faculty of Pharmaceutical Sciences, University of Central Punjab (UCP), Lahore, 54000, Pakistan., Irfan A; Department of Chemistry, Government College University Faisalabad, Faisalabad, 38000, Pakistan., Khalid M; Faculty of Pharmaceutical Sciences, University of Central Punjab (UCP), Lahore, 54000, Pakistan., Sohail MF; Department of Chemistry, SBASSE, Lahore University of Management Sciences (LUMS), Lahore, 54000, Pakistan.; Alliant College of Pharmacy and Allied Health Sciences, Lahore, 54000, Pakistan.

Publikováno v: Functional & integrative genomics [Funct Integr Genomics] 2024 Sep 28; Vol. 24 (5), pp. 177. Date of Electronic Publication: 2024 Sep 28.

Seroprevalence of SARS-CoV-2 and humoral immune responses to COVID-19 mRNA vaccines among people who use drugs - in the light of tailored mitigating strategies.

Autor: Wüsthoff LEC; Unit for Clinical Research on Addictions, Oslo University Hospital, PO Box 4959 Nydalen, Oslo, 0424, Norway. linwus@ous-hf.no.; Norwegian Centre for Addiction Reasearch, Institute of Clinical Medicine, University of Oslo, PO Box 1039 Blindern, Oslo, 0315, Norway. linwus@ous-hf.no., Lund-Johansen F; Department of Immunology, Oslo University Hospital, PO Box 4950 Nydalen, Oslo, 0424, Norway.; ImmunoLingo Convergence Center, Institute of Clinical Medicine, University of Oslo, Gaustadalleen 21, Oslo, 0349, Norway.; Institute of Clinical Medicine, University of Oslo, PO Box 1171 Blindern, Oslo, 0318, Norway.; Precision Immunotherapy Alliance, Institute of Clinical Medicine, University of Oslo, PO Box 1171 Blindern, 0318, Oslo, Norway., Henriksen K; Agency for Social and Welfare Services, Oslo Municipality, PO Box 30 Sentrum, Oslo, 0101, Norway.; Student Health Services, Student Welfare Services in Oslo, Problemveien 9, Oslo, 0313, Norway., Wildendahl G; Agency for Social and Welfare Services, Oslo Municipality, PO Box 30 Sentrum, Oslo, 0101, Norway., Jacobsen JA; Agency for Social and Welfare Services, Oslo Municipality, PO Box 30 Sentrum, Oslo, 0101, Norway., Gomes L; Agency for Social and Welfare Services, Oslo Municipality, PO Box 30 Sentrum, Oslo, 0101, Norway., Anjum HS; Agency for Social and Welfare Services, Oslo Municipality, PO Box 30 Sentrum, Oslo, 0101, Norway., Barlinn R; Department of Microbiology, Oslo University Hospital, PO Box 4950 Nydalen, Oslo, 0424, Norway., Kran AB; Division of Infection Control, Norwegian Institute of Public Health, PO Box 222 Skøyen, Oslo, 0213, Norway., Munthe LA; Department of Immunology, Oslo University Hospital, PO Box 4950 Nydalen, Oslo, 0424, Norway.; KG Jebsen Centre for B cell Malignancies, and Precision Immunotherapy Alliance, Institute of Clinical Medicine, University of Oslo, PO Box 4950 Nydalen, Oslo, 0424, Norway., Vaage JT; Department of Immunology, Oslo University Hospital, PO Box 4950 Nydalen, Oslo, 0424, Norway.; Institute of Clinical Medicine, University of Oslo, PO Box 1171 Blindern, Oslo, 0318, Norway.

Publikováno v: Harm reduction journal [Harm Reduct J] 2024 Jun 19; Vol. 21 (1), pp. 120. Date of Electronic Publication: 2024 Jun 19.

Solid Self-Nanoemulsifying Drug Delivery Systems of Furosemide: In Vivo Proof of Concept for Enhanced Predictable Therapeutic Response.

Autor: Gul S; Department of Pharmaceutics, Faculty of Pharmacy, Bahauddin Zakariya University, Multan 60800, Pakistan., Sridhar SB; RAK College of Pharmacy, RAK Medical & Health Sciences University, Ras al Khaimah 11172, United Arab Emirates., Jalil A; Department of Pharmaceutics, Faculty of Pharmacy, Bahauddin Zakariya University, Multan 60800, Pakistan., Akhlaq M; Department of Pharmacy, Hazara University, Mansehra 21300, Pakistan., Arshad MS; Department of Pharmaceutics, Faculty of Pharmacy, Bahauddin Zakariya University, Multan 60800, Pakistan., Sarwar HS; Department of Pharmaceutical Sciences, University of Central Punjab, Lahore 54590, Pakistan., Usman F; Department of Pharmaceutics, Faculty of Pharmacy, Bahauddin Zakariya University, Multan 60800, Pakistan., Shareef J; RAK College of Pharmacy, RAK Medical & Health Sciences University, Ras al Khaimah 11172, United Arab Emirates., Thomas S; College of Health Sciences, University of Nizwa, Birkat Al Mouz, Nizwa 616, Oman.

Publikováno v: Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2024 Apr 14; Vol. 17 (4). Date of Electronic Publication: 2024 Apr 14.

Injectable Chitosan-Methoxy Polyethylene Glycol Hybrid Hydrogel Untangling the Wound Healing Behavior: In Vitro and In Vivo Evaluation.

Autor: Mushtaq F; Riphah International University (R.I.U.), Riphah Institute of Pharmaceutical Sciences (RIPS), Lahore, Punjab 54000, Pakistan., Ashfaq M; Riphah International University (R.I.U.), Riphah Institute of Pharmaceutical Sciences (RIPS), Lahore, Punjab 54000, Pakistan., Anwar F; Riphah International University (R.I.U.), Riphah Institute of Pharmaceutical Sciences (RIPS), Lahore, Punjab 54000, Pakistan., Ayesha BT; Riphah International University (R.I.U.), Riphah Institute of Pharmaceutical Sciences (RIPS), Lahore, Punjab 54000, Pakistan., Latif HS; Fatima Jinnah Medical University, Lahore 54000, Pakistan., Khalil S; Riphah International University (R.I.U.), Riphah Institute of Pharmaceutical Sciences (RIPS), Lahore, Punjab 54000, Pakistan., Sarwar HS; Faculty of Pharmacy, University of Central Punjab, Lahore 54000, Pakistan., Khan MI; Riphah International University (R.I.U.), Riphah Institute of Pharmaceutical Sciences (RIPS), Lahore, Punjab 54000, Pakistan., Sohail MF; Riphah International University (R.I.U.), Riphah Institute of Pharmaceutical Sciences (RIPS), Lahore, Punjab 54000, Pakistan., Maqsood I; Riphah International University (R.I.U.), Riphah Institute of Pharmaceutical Sciences (RIPS), Lahore, Punjab 54000, Pakistan.; Department of Pharmaceutics, School of Pharmacy, University of Maryland, Baltimore, Maryland 21201, United States.

Publikováno v: ACS omega [ACS Omega] 2023 Dec 29; Vol. 9 (2), pp. 2145-2160. Date of Electronic Publication: 2023 Dec 29 (Print Publication: 2024).